Logo Logo
Switch Language to German
Ou, Baochi; Zhao, Jingkun; Guan, Shaopei; Feng, Hao; Wangpu, Xiongzhi; Zhu, Congcong; Zong, Yaping; Ma, Junjun; Sun, Jing; Shen, Xiaohui; Zheng, Minhua; Lu, Aiguo (2016): CCR4 promotes metastasis via ERK/NF-kappa B/MMP13 pathway and acts downstream of TNF-alpha in colorectal cancer. In: Oncotarget, Vol. 7, No. 30: pp. 47637-47649
Full text not available from 'Open Access LMU'.


Chemokines and chemokine receptors are causally involved in the metastasis of human malignancies. As a crucial chemokine receptor for mediating immune homeostasis, however, the role of CCR4 in colorectal cancer (CRC) remains unknown. In this study, we found that high expression of CCR4 in CRC tissues was correlated with shorter overall survival and disease free survival. In vitro and in vivo experiments revealed that silencing CCR4 attenuated the invasion and metastasis of CRC cells, whereas ectopic overexpression of CCR4 contributed to the forced metastasis of these cells. We further demonstrated that matrix metalloproteinase 13 (MMP13) played an important role in CCR4-mediated cancer cell invasion, which is up-regulated by ERK/NF-kappa B signaling. Positive correlation between CCR4 and MMP13 expression was also observed in CRC tissues. Moreover, our investigations showed that the level of CCR4 could be induced by TNF-alpha dependent of NF-kappa B activation in CRC cells. CCR4 might be implicated in TNF-alpha-regulated cancer cells metastasis. Combination of CCR4 and TNF-alpha is a more powerful prognostic marker for CRC patients. These findings suggest that CCR4 facilitates metastasis through ERK/NF-kappa B/MMP13 signaling and acts as a downstream target of TNF-alpha. CCR4 inhibition may be a promising therapeutic option for suppressing CRC metastasis.